Records 1 - 9
| Association of DNA Repair Genes XRCC1 and APE-1 with the Risk of Cervical Cancer in North Indian population.
Asian Pacific journal of cancer prevention : APJCP 2020 Jul 21 (7): 2061-2065.
Charles Mark Rector, Raza Syed Tasleem, Sharma Rolee, Pratap Pushpendra, Eba Ale, Singh Manvend
| Effects of polymorphic DNA genes involved in BER and caspase pathways on the clinical outcome of myeloproliferative neoplasms under treatment with hydroxyurea.
Molecular medicine reports 2018 Oct .
Azevedo Ana P, Silva Susana N, Reichert Alice, Lima Fernando, Júnior Esmeraldina, Rueff Jo
| Role of depth of response and MTHFR genotype as predictors of fluorouracil rechallenge therapy for refractory metastatic colorectal cancer.
Oncology letters 2017 Aug 14 (2): 2491-2498.
Kim Ka-Rham, Yoon Jung-Hwan, Shim Hyun-Jeong, Hwang Jun-Eul, Bae Woo-Kyun, Chung Ik-Joo, Kim Hee-Nam, Shin Min-Ho, Cho Sang-H
| Association of XPD (Lys751Gln) and XRCC1 (Arg280His) gene polymorphisms in myelodysplastic syndrome.
Annals of hematology 2015 Oct .
Joshi Dolly, Korgaonkar Seema, Shanmukhaiah Chandrakala, Vundinti Babu R
| Polymorphisms in ERCC1 C8092A predict progression-free survival in metastatic/recurrent nasopharyngeal carcinoma treated with cisplatin-based chemotherapy.
Cancer chemotherapy and pharmacology 2013 Aug 72 (2): 315-22.
Chen Cui, Wang Fenghua, Wang Zhiqiang, Li Cong, Luo Huiyan, Liang Ying, An Xin, Shao Jianyong, Li Yuho
| Genetic polymorphisms of GSTP1 and XRCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC) patients.
Swiss medical weekly 2011 141 w13275.
Zhou Fei, Yu Zhuang, Jiang Tao, Lv Hongying, Yao Ruyong, Liang J
| The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer.
Cancer chemotherapy and pharmacology 2010 Aug 66 (3): 493-500.
Liang Jun, Jiang Tao, Yao Ru-yong, Liu Zi-min, Lv Hong-ying, Qi Wei-w
| A pharmacogenomic study of docetaxel and gemcitabine for the initial treatment of advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007 Mar 2 (3): 197-202.
Petty W Jeffrey, Knight Sommer N, Mosley Libyadda, Lovato James, Capellari James, Tucker Robert, Blackstock A William, Miller Mark Steven, Miller Antonius
| A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer.
British journal of cancer 2004 Jul 91 (2): 344-54.
Stoehlmacher J, Park D J, Zhang W, Yang D, Groshen S, Zahedy S, Lenz H